£97.00 ($1.28)

-1.00 (-1.02%)

Weekly Expected Move ±4.4%

£90 £94 £98 £102 £107

LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 61 · £65.4M mcap · 59M float · 0.229% daily turnover

Analysis Technicals Weather Peers

Revenue

$80M -11.0% ▼

5Y CAGR: +2.0%

Gross Profit

$36M -4.7% ▼

5Y CAGR: +2.1%

Operating Income

$4M +21.7% ▲

5Y CAGR: -7.9%

Net Income

$2M +60.9% ▲

5Y CAGR: -15.4%

EPS (Diluted)

$0.02 +59.9% ▲

5Y CAGR: -15.2%

EBITDA

$7M +11.6% ▲

5Y CAGR: -0.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$106M	$82M	$85M	$89M	$80M
YoY Growth	+46.5%	-22.2%	+3.8%	+4.8%	-11.0%
Cost of Revenue	$54M	$48M	$49M	$52M	$44M
Gross Profit	$52M	$34M	$37M	$38M	$36M
Gross Margin	48.8%	41.0%	43.1%	42.1%	45.1%
R&D Expenses	$8M	$9M	$6M	$4M	$4M
SG&A Expenses	$27M	$20M	$26M	$29M	$29M
Operating Expenses	$35M	$29M	$32M	$34M	$32M
Operating Income	$17M	$5M	$5M	$4M	$4M
Operating Margin	16.0%	5.5%	5.9%	4.0%	5.4%
Interest Expense	$302K	$284K	$656K	$764K	$452K
Income Before Tax	$19M	$1M	$4M	$3M	$4M
Tax Expense	$3M	$2M	$1M	$966K	$1M
Net Income	$7M	-$686K	$1M	$1M	$2M
Net Margin	6.9%	-0.8%	1.2%	1.2%	2.1%
EPS (Diluted)	$0.11	$-0.01	$0.01	$0.02	$0.02
EBITDA	$19M	$4M	$7M	$7M	$7M
Shares Outstanding	68M	68M	69M	69M	69M

Line Item	FY2021 Q4	FY2022 Q2	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2
Revenue	$44M	$35M	$50M	$38M	$51M	$33M	$46M	$39M
Cost of Revenue	$27M	$20M	$28M	$23M	$29M	$20M	$24M	$20M
Gross Profit	$17M	$15M	$23M	$16M	$22M	$13M	$23M	$20M
Gross Margin	39.0%	43.7%	44.8%	40.8%	43.1%	40.3%	48.6%	49.6%
R&D Expenses	$5M	$3M	$3M	$2M	$2M	$2M	$2M	$3M
SG&A Expenses	$12M	$12M	$16M	$14M	$15M	$12M	$15M	$16M
Operating Expenses	$17M	$15M	$19M	$16M	$18M	$15M	$17M	$19M
Operating Income	-$365K	$268K	$4M	-$612K	$4M	-$1M	$6M	$1M
Operating Margin	-0.8%	0.8%	7.5%	-1.6%	8.0%	-4.0%	12.0%	2.6%
Interest Expense	$41K	$95K	$457K	$166K	$598K	$336K	$116K	$177K
Income Before Tax	$509K	$3M	$1M	-$673K	$4M	-$1M	$5M	$1M
Tax Expense	$1M	$929K	$420K	$580K	$386K	$343K	$1M	$349K
Net Income	-$546K	$1M	-$317K	-$1M	$2M	-$2M	$3M	-$363K
Net Margin	-1.2%	3.8%	-0.6%	-3.4%	4.6%	-5.1%	7.3%	-0.9%
EPS (Diluted)	$-0.01	$0.02	$-0.00	$-0.02	$0.03	$-0.03	$0.05	$-0.01
EBITDA	$2M	$4M	$5M	$681K	$6M	$206K	$7M	$3M
Shares Outstanding	68M	68M	68M	68M	69M	68M	69M	68M

EAH.L LSE